MCRB 8-K 2026-06-05

Seres Therapeutics, Inc. (MCRB) 8-K dated 2026-06-05 — accession 0001193125-26-258366. This URL is the filing, not the MCRB hub.

Seres Therapeutics, Inc. (MCRB) is a biotechnology company listed on US.

Seres Therapeutics, Inc. filed a 8-K on 2026-06-05. Accession 0001193125-26-258366.

Cached items: 1.01, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.

Not investment advice. The MCRB SEC hub lists recent forms. The stock page is the research view.